allo stock

leading the future of cell therapy with our allocar t™ platform innovation multiplex gene-engineering and gene-editing capabilities proprietary lymphodepletion platform state-of-the-art manufacturing opportunity for product optimization see our pioneering platform >> pipeline cd19 allo-501a – phase 1 bcma allo-715 – phase 1 allo-715 + nirogacestat – phase 1 allo-605 – phase 1 cd70 allo-316 – phase 1 […]